We are live on ! Find out more
FCMI

Foresite Capital Management I Portfolio holdings

AUM $21.4M
1-Year Est. Return 80.48%
This Fund
S&P 500
This Quarter Est. Return
-26.77%
1 Year Est. Return
-80.48%
3 Year Est. Return
-40.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.1M
AUM Growth
-$6.59M
Cap. Flow
-$1.15M
Cap. Flow %
-7.57%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$2.2M

Top Sells

Rank Stock Value
1
RXDX
Ignyta, Inc.
RXDX
+$3.35M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OREX
1
DELISTED
Orexigen Therapeutics, Inc.
OREX
$6.08M 40.17%
122,929
– –
XLRN
2
DELISTED
Acceleron Pharma
XLRN
$5.13M 33.85%
162,070
+68,289
+73% +$2.2M
BDSI
3
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$3.94M 25.98%
494,468
– –
RXDX
4
DELISTED
Ignyta, Inc.
RXDX
– –
-336,766
Closed -$3.35M

Similar funds

A
Atlassian San Francisco, California $21M AUM 71.86% 1-Year Est. Return
CVGI
Craft Ventures GP II San Francisco, California $24.1M AUM 83.06% 1-Year Est. Return
AEPI
AH Equity Partners IV Menlo Park, California $24.5M AUM 73.4% 1-Year Est. Return
AGDR
AdamCapital Gestao de Recursos Rio De Janeiro, Brazil $18.1M AUM 32.38% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
WL
WiL LLC Palo Alto, California $17.5M AUM 75.04% 1-Year Est. Return
NVPX
Norwest Venture Partners XIII Palo Alto, California $25.8M AUM 76.52% 1-Year Est. Return
SVGI
Sozo Ventures GP I Redwood City, California $16.3M AUM 66.18% 1-Year Est. Return

Foresite Capital Management I's Q2 2015 Portfolio in Review

As of Q2 2015, Foresite Capital Management I held 4 positions worth $15.1M, down 30% from $21.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management I withdrew a net $1.15M in Q2 2015, closing 1 position. Its most notable exit was Ignyta, Inc., an estimated $3.35M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Foresite Capital Management I added an estimated $2.2M to Acceleron Pharma.

  • Foresite Capital Management I added most to Acceleron Pharma in Q2 2015, an estimated $2.2M increase.
  • Foresite Capital Management I fully exited Ignyta, Inc. in Q2 2015, selling an estimated $3.35M.
  • Foresite Capital Management I's ten largest holdings make up 100% of its $15.1M portfolio in Q2 2015.
  • Foresite Capital Management I opened 0 new positions and closed 1 in Q2 2015.
  • Foresite Capital Management I's portfolio value fell 30% quarter-over-quarter to $15.1M.

Based on Foresite Capital Management I's 13F filing for Q2 2015, filed 14 Aug 2015.